Warning: Undefined array key "network" in /hshare1/ZETTAI_path_WA_slash_usr_slash_proj_KARA/usr/proj/tcng/htdocs/tcng.php on line 565
Edge
PGK1 → KPNA1
Networks Including this Edge
| GSE10072_egf1520 - GSE10072 - SiGN-BN HC+Bootstrap | Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival |
| GSE10780_egf1520 - GSE10780 - SiGN-BN HC+Bootstrap | Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue |
| GSE10843_egf1520 - GSE10843 - SiGN-BN HC+Bootstrap | mRNA Cancer Cell Line Profiles |
| GSE14814_egf1520 - GSE14814 - SiGN-BN HC+Bootstrap | Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer |
| GSE14925_egf1520 - GSE14925 - SiGN-BN HC+Bootstrap | Expression data from Non small cell lung cancer cell lines |
| GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| GSE17951_egf1520 - GSE17951 - SiGN-BN HC+Bootstrap | Gene expression analysis of prostate cancer samples using Affymetrix U133Plus2 array |
| GSE21653_egf1520 - GSE21653 - SiGN-BN HC+Bootstrap | A gene expression signature identifies two prognostic subgroups of basal breast cancer |
| GSE24185_egf1520 - GSE24185 - SiGN-BN HC+Bootstrap | Gene transcription signature of obesity in breast cancer |
| GSE29598_egf1520 - GSE29598 - SiGN-BN HC+Bootstrap | A Methodology for Utilization of Predictive Genomic Signatures in FFPE Samples |
| GSE30375_egf1520 - GSE30375 - SiGN-BN HC+Bootstrap | Gene expression data from sorted and unsorted primary human acute myeloid leukemia (AML) samples |
| GSE3141_egf1520 - GSE3141 - SiGN-BN HC+Bootstrap | Lung Cancer Dataset |
| GSE3593_egf1520 - GSE3593 - SiGN-BN HC+Bootstrap | Genomic approach to refine prognosis for adjuvant therapy in early stage non-small cell lung carcinoma |
| GSE4115_egf1520 - GSE4115 - SiGN-BN HC+Bootstrap | Airway Epithelial Gene Expression Diagnostic for the Evaluation of Smokers with Suspect Lung Cancer |
| GSE5462_egf1520 - GSE5462 - SiGN-BN HC+Bootstrap | Letrozole (Femara) early response to treatment |
